Clinical trial · Observational
Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer
NCT06444477CI-TRIAL-00101625MATACcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The association between hematologic malignancies and ITP is well described, but this link is much less clear with solid cancers. In cases of ITP associated with cancers, specific cancer treatment can lead to remission or even cure of ITP. Thus, our hypothesis was that chronic expression of GPIIB by tumor cells could have initiated an autoimmune loop against GPIIB, leading to the onset and perpetuation of ITP.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Immune Thrombocytopenia | — | UNRESOLVED | — |
| Immune Thrombocytopenic Purpura | — | UNRESOLVED | — |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ITP and cancer | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with a definite diagnosis of both ITP and cancer
- interventionNames
- Other: ITP and cancer
Primary outcomes (1)
- measure
- Remission rate of ITP at 6 months after specific cancer treatment
- timeFrame
- At baseline (Day 0)
Secondary outcomes (7)
- measure
- All-cause mortality
- timeFrame
- At baseline (Day 0)
- measure
- Side effects related to ITP and its treatment
- timeFrame
- At baseline (Day 0)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients with a definite diagnosis of both ITP and cancer; * Synchronous diagnosis of ITP and cancer; * Onset of ITP occurring 6 months before or after the diagnosis of cancer. Exclusion Criteria: * None
References
Publications (0)
Data not yet available
No reference posted for this study.